Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.620
-0.210 (-4.35%)
Nov 17, 2026, 4:00 PM EST - Market closed
Evolent Health Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Evolent Health stock has a consensus rating of "Buy" and an average price target of $6.00. The average 1-year stock price forecast is 29.87% higher than the current stock price, while the lowest is $3.00 (-35.06%) and the highest is $8.00 (+73.16%).
Price Target: $6.00 (+29.87%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Evolent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 6 | 8 | 7 | 7 | 7 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 3 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 14 | 15 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $6 | Buy | Maintains | $6 | +29.87% | Nov 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $6 | Buy | Maintains | $6 | +29.87% | Nov 9, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 6, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +51.52% | Nov 6, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $3 | Hold | Maintains | $3 | -35.06% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
2.64B
from 1.88B
Increased by 40.76%
Revenue Next Year
3.32B
from 2.64B
Increased by 25.65%
EPS This Year
0.23
from 0.09
Increased by 159.02%
EPS Next Year
0.42
from 0.23
Increased by 81.40%
EPS and Forward PE are based on non-GAAP adjusted numbers.